ADHD costs may rise 14-fold

Attention-deficiency hyperactivity disorder (ADHD) drug costs for the NHS are set to soar with increased diagnosis of the condition in children and adolescents in the UK, claim German researchers.

Predictions are that the estimated £7 million spend on ADHD by the NHS in 2002 will rise to between £49 and £101 million a year in 2012.

The overall drug expenditure by doctors for ADHD may increase between two- and nine-fold.

The estimates come from Professor Michael Schlander, from the University of Heidelberg.

He calculated the range of possible costs by considering likelihood of diagnosis and treatment, the level of treatment and drug costs.

Visit the Child and Adolescent Psychiatry and Mental Health website

Comment below and tell us what you think 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in